Profile and Outcome of Childhood Tuberculosis Treated with DOTS--an Observational Study
Overview
Affiliations
Objectives: To study the clinical profile and outcome of childhood tuberculosis treated with Directly Observed Treatment Short (DOTS) course regimen. Also to study the side effects of anti-tubercular treatment (ATT).
Methods: This prospective hospital based observational study was conducted at Department of Pediatrics, Karnataka Institute of Medical Sciences (KIMS), Hubli. Inclusion criteria were i) All newly diagnosed cases of tuberculosis from 0 to 12 y of age. ii) Children with relapse, treatment failure or defaulters. Exclusion criteria was children with tuberculosis on anti-tubercular treatment (ATT) other than DOTS regimen. A detailed history including demographic profile and clinical examination were carried out for each case. Diagnosis, categorization, treatment (DOTS regimen) and outcome measures were defined according to WHO/RNTCP guidelines. Data was analyzed using SPSS 17.
Results: Total number of children enrolled in the study were 93. Mean age was 6 y. Male to female ratio was 0.9:1. Extra pulmonary tuberculosis (EPTB) was common 58 (62.4 %) than pulmonary tuberculosis 35 (37.6 %). The common symptoms/signs were fever (83.8 %), cough (46.2 %), convulsion (17.2 %), loss of appetite (11.8 %) and pallor (75.3 %), lymphadenopathy (18.3 %), hepatomegaly (9.7 %) and splenomegaly (6.5 %). Mantoux test was positive in 59 (63.4 %) children. Acid fast bacilli (AFB) was isolated in 13 (14 %) children in various fluid/histological specimens. The prevalence of HIV infection was 7.5 %. Among 93 children, 88(94.6 %) completed treatment and were declared cured; four children were lost to follow up and one child died. Compliance of DOTS was good and there were no side effects due to ATT.
Conclusions: EPTB was common than pulmonary TB. Efficacy of DOTS in index study was 94.6 %. No adverse effects of ATT were observed.
Chiabi A, Wirngo T, Yves Bassong P, Ngoufo F, Ngum E, Angwafor S Turk Arch Pediatr. 2023; 58(2):154-158.
PMID: 36856352 PMC: 10081072. DOI: 10.5152/TurkArchPediatr.2023.22228.
Wang M, Wang J, Liu X Biomed Res Int. 2020; 2020:6142567.
PMID: 32851083 PMC: 7436284. DOI: 10.1155/2020/6142567.
Dodd P, Prendergast A, Beecroft C, Kampmann B, Seddon J Thorax. 2017; 72(6):559-575.
PMID: 28115682 PMC: 5520282. DOI: 10.1136/thoraxjnl-2016-209421.
Six months therapy for tuberculous meningitis.
Jullien S, Ryan H, Modi M, Bhatia R Cochrane Database Syst Rev. 2016; 9:CD012091.
PMID: 27581996 PMC: 5018659. DOI: 10.1002/14651858.CD012091.pub2.
Tuberculosis treatment outcomes among peri-urban children receiving doorstep tuberculosis care.
Jeena L, Naidoo K Int J Tuberc Lung Dis. 2016; 20(2):235-9.
PMID: 26792477 PMC: 4989031. DOI: 10.5588/ijtld.15.0090.